Community social vulnerability and the 340B Drug Pricing Program: Evaluating predictors of 340B participation among critical access hospital

Purpose The federal 340B Drug Pricing Program allows eligible hospitals, including critical access hospitals (CAHs), to obtain outpatient drugs at a discounted rate. CAHs likely benefit from 340B participation because they are often under‐resourced and serve at‐risk patient populations. The objectiv...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:The Journal of rural health Ročník 40; číslo 4; s. 720 - 727
Hlavní autori: Owsley, Kelsey M., Karim, Saleema A.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England Wiley Subscription Services, Inc 01.09.2024
Predmet:
340B program
Access
Acute services
Bivariate analysis
Community
Community involvement
critical access
Cross-Sectional Studies
discount rate
Drug prices
Drugs
Health Services Accessibility - economics
Health Services Accessibility - standards
Health Services Accessibility - statistics & numerical data
Hospitals
Humans
Participation
Patients
Population studies
Populations
Pricing
probability
Regression analysis
Regression models
rural
rural health
Social Vulnerability
Socioeconomic status
Socioeconomics
Statistical analysis
United States
Vulnerability
United States
340B program
hospitals
rural
critical access
ISSN:0890-765X, 1748-0361, 1748-0361
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Purpose The federal 340B Drug Pricing Program allows eligible hospitals, including critical access hospitals (CAHs), to obtain outpatient drugs at a discounted rate. CAHs likely benefit from 340B participation because they are often under‐resourced and serve at‐risk patient populations. The objective of this study was to understand predictors of 340B program participation among CAHs, and how participation varies with community‐level social vulnerability. Methods We used a cross‐sectional study design to assess the relationship between 340B participation in 2019 and community vulnerability status using 2018 data from the CDC's social vulnerability index (SVI) among acute care CAHs. Analyses used linear probability models adjusted for hospital‐level characteristics. Findings In bivariate analyses, CAHs participating in the 340B program had lower overall social vulnerability scores, relative to nonparticipating, eligible, and ineligible CAHs, respectively (43.8 vs. 48.7 vs. 64.7, p < 0.10). In adjusted regression models, greater community vulnerability rankings due to socioeconomic status (–0.129, p < 0.05) and minority status and language (–0.092, p < 0.05) were associated with decreased 340B participation. Higher hospital operating margin was associated with increased 340B participation (0.163, p < 0.05). Although the number of for‐profit CAHs ineligible for 340B was small, they had the highest community‐level social vulnerability score and lowest hospital operating margin on average. Conclusions CAHs located in areas of high community vulnerability are less likely to participate in the 340B program. Some vulnerable patient populations served by CAHs may be excluded from 340B program benefits.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0890-765X
1748-0361
1748-0361
DOI:10.1111/jrh.12833